FDA approves sulfate-based table preparation for colonoscopy

Sebela Pharamceuticals received FDA approval for its sulfate-based tablet preparation for colonscopy.Accoridng a press release, the sodium sulfate, magnesium sulfate and potassium chloride tablet – known as SUTAB – will be marketed by Braintree Laboratories.“Gastroenterologists and their patients have repeatedly asked for a safe and efficacious tablet bowel prep.” Alan Cooke, president and CEO of Sebela Pharmaceuticals, said in the release. “Now patients can benefit from SUTAB, thanks to Braintree’s innovative and dedicated team, who have worked tirelesslyRead More

Share on facebook
Share on twitter
Share on linkedin